Search Results for: jamie thomson

Stem cell weekly reads: Jamie Thomson, Lamin B1, CRISPR

james-a.-thomson-214x3001

The big news of the week was a $3.6 million settlement by a stem cell clinic, StemGenex, and one of its doctors in a class-action suit. I covered this StemGenex settlement and so did Michael Hiltzik of the LA Times and Paul Schloesser at Endpoints. I’d say this was good news for the stem cell field […]

Stem cell weekly reads: Jamie Thomson, Lamin B1, CRISPR Read More »

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s

Knoepfler lab stem cells

Early during my postdoc I was primarily interested in the role of Myc genes both in cancer and in stem cells, work that later included embryonic stem cells. These cells are often called ES cells. At first I first started studying N-Myc in neural stem cells using a conditional knockout approach. However, soon after I was

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s Read More »

What are induced pluripotent stem cells or IPS cells?

induced pluripotent stem cells clinical trials map

Induced pluripotent stem cells or iPS cells just might be the most exciting development in the stem cell field over the last 15 years. They have unique potential for clinical impact for regenerative medicine too. This may manifest both through their use to produce differentiated cellular therapies and indirectly via disease modeling as well as

What are induced pluripotent stem cells or IPS cells? Read More »

Supreme Court Rejection of WARF hESC Patent Challenge Discussion

james-a.-thomson-214x3001

The challenge to the WARF/Jamie Thomson patents/IP on human embryonic stem cells (hESC) is at an end. The US Supreme Court declined to hear the case. Earlier, the USPTO had turned down the challenge leading to a winding road in the courts. What do you all think of this stem cell IP challenge and the

Supreme Court Rejection of WARF hESC Patent Challenge Discussion Read More »

Did Nobel folks get it right & no one deserved 3rd stem cell slot with Yamanaka & Gurdon?

The great news of Yamanaka and Gurdon getting the Nobel Prize for cellular reprogramming is still resonating in the stem cell field. My heartfelt congratulations to two amazing biologists! Also still ringing in my ears from so many people contacting me about what is becoming a somewhat infamous “empty” third slot that the Nobel Committee

Did Nobel folks get it right & no one deserved 3rd stem cell slot with Yamanaka & Gurdon? Read More »

Nobel Prize 2012 for stem cells to Yamanaka & Gurdon: why only 2?

Nobel-Prize

Stem cell revolutionaries Drs. Shinya Yamanaka and John Gurdon have won the 2012 Nobel Prize for Physiology or Medicine. Gurdon cloned for the first animal, a frog, and Yamanaka produced induced pluripotent stem cells (iPSCs), a kind of stem cell with the power of pluripotency, but derived from ordinary non-stem cells. Gurdon’s work was based

Nobel Prize 2012 for stem cells to Yamanaka & Gurdon: why only 2? Read More »